PMA P210006S005

Device
Thoraflex Hybrid
Applicant
Vascutek, Ltd.
PMA number
P210006
Supplement
S005
Product code
QSK
Decision date
2023-11-20
Classification
Cardiovascular
Generic name
Hybrid stent graft, thoracic aortic lesion treatment
Approval order statement
Approval for a change in equipment used to manufacture the delivery system and a change in cleaning method for the stainless-steel shaft component of the delivery system.

Current openFDA PMA Record

Device
Thoraflex Hybrid
Applicant
Vascutek, Ltd.
PMA number
P210006
Supplement
S005
Product code
QSK
Generic name
Hybrid stent graft, thoracic aortic lesion treatment
Decision date
2023-11-20
Decision code
APPR
Date received
2023-07-27
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for a change in equipment used to manufacture the delivery system and a change in cleaning method for the stainless-steel shaft component of the delivery system.

Related Records